[ Back to EurekAlert! ]

Contact: Lucky Tran
Columbia University Medical Center

Vision of Patients with Retinitis Pigmentosa (2 of 2)

Caption: These ar eimages of normal (above) and diseased retinas. Patients with MFRP mutations, a cause of retinitis pigmentosa, lose the function of most retinal cells, particularly at the periphery of the retina, leaving them with drastically reduced vision. Personalized gene therapy, using iPS cells, may offer a way to correct this genetic disorder.

Credit: Columbia University Medical Center

Usage Restrictions: None

Related news release: Patient-specific stem cells and personalized gene therapy

[ Back to EurekAlert! ]